Symbol | Exchange | Currency |
---|
PT Taisho Pharmaceutical Indonesia Tbk engages in the development, registration, processing, production, and sale of chemical, pharmaceutical, and health care products. The company offers over-the-counter products, including Counterpain, Tempra, multi-vitamin, and skin care products, as well as ethical products in domestic and export markets. Its products are offered in the form of tablets, capsules, ointments, powders, patches, and other forms. The company was formerly known as PT Squibb Indonesia and changed its name to PT Taisho Pharmaceutical Indonesia Tbk in November 2009. The company was founded in 1970 and is headquartered in Jakarta, Indonesia. PT Taisho Pharmaceutical Indonesia Tbk is a subsidiary of Taisho Pharmaceutical Co., Ltd.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
---|---|---|---|---|---|
Moving Averages | |||||
Technical Indicators | |||||
Summary |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
---|---|---|---|---|---|---|---|---|---|
195.28 | 197.33 | 194.42 | +1.40 | +0.72% | 109.50M | NASDAQ | |||
162.36 | 162.47 | 161.27 | +1.59 | +0.99% | 46.76M | NASDAQ | |||
61.85 | 62.09 | 61.66 | -0.01 | -0.02% | 8.35M | NYSE | |||
207.84 | 208.09 | 202.82 | +2.49 | +1.21% | 22.53M | NASDAQ | |||
100.89 | 101.15 | 99.78 | -0.50 | -0.49% | 32.74M | NASDAQ | |||
284.05 | 284.46 | 281.48 | +3.54 | +1.26% | 24.97M | NASDAQ | |||
40.38 | 40.49 | 40.25 | +0.13 | +0.32% | 12.49M | NYSE | |||
97.88 | 99.53 | 97.25 | +1.79 | +1.86% | 58.34M | NASDAQ | |||
102.00 | 103.04 | 101.01 | +1.75 | +1.75% | 51.96M | NASDAQ | |||
162.67 | 164.50 | 162.41 | +0.54 | +0.33% | 1.16M | NASDAQ | |||
273.83 | 274.99 | 271.02 | +3.99 | +1.48% | 35.62M | NASDAQ | |||
8.15 | 8.38 | 8.05 | -0.07 | -0.85% | 20.57M | NYSE | |||
101.32 | 101.61 | 100.29 | -0.58 | -0.57% | 24.17M | NASDAQ | |||
46.51 | 47.32 | 46.02 | -0.19 | -0.41% | 12.10M | NYSE | |||
10.27 | 10.275 | 10.27 | -0.010 | -0.10% | 66.38K | NYSE |